Pharma Reps’ Worst Fear Is Near: Outsourced to the Internet!
When eDetailing was relatively new in 2003 -- before the dawn of Web 2.0 -- there were about 90,000 pharmaceutical sales reps. In 2007,...
CBI’s 2nd Annual Bio/Pharmaceutical Forum on Effective and Compliant Advisory Boards
Ensure Appropriate Objectives, Structure and Transparency
Do Fat People Like Wynonna Judd’s Music? GSK and alli May Think They Do.
"Consumers purchasing GlaxoSmithKline's weight loss drug Alli will receive a free copy of Wynonna Judd's new album Sing," reports MM&M (see "GSK pairs Wynonna...
Protracted Decline in US Rx Sales Growth Portends Dire Future for Industry, Unless…
"We ration care in the US today using one of the most capricious and inequitable means possible -- ability to pay," says Kim Slocum,...
Pharma Companies Anticipate My Survey Results and Expand Prescription Savings Program to Cover More...
According to a Pfizer press release, Pfizer Inc announced today that Together Rx Access™, a prescription savings program sponsored by Pfizer along with several...
Future Health Care Scenarios. Which is Best for Pharma?
I think everyone should listen to my podcast interview of Kim Slocum, former Director, Strategic Planning & Business Development at AstraZeneca, who suggested...
Big Pharma: Going Global or Going Postal?
Is it just me or is the guy on the cover of this month's PharmaVoice magazine a little bit scary looking?He has that look...
CNTO411: We’ll Meet Again, Don’t Know Where, Don’t Know When
Remember Centocor's corporate/disease awareness blog, CNTO411? A few weeks ago I predicted that this blog would soon be taken down because Centocor cannot find...
Pharma Dreams of Dipping Its Toe Into Social Networking Waters
Before YOU dip your toe into social media marketing, shouldn't you understand your company's unique regulatory environment, corporate culture, and knowledge, all of which...
Botox v. Reloxin: Market Share Battle May Revive DTC Spending Late in 2009
If you thought the DTC advertising sleep aid (Lunesta v. AmbienCR v. Rozerem) advertising war was excessive, wait until Reloxin is approved for marketing...
